EquityFlow
›
Companies
› Actimed Therapeutics
Actimed Therapeutics
Biotech
· London, GB ·
actimedtx.com
Clinical-stage pharma for cancer cachexia
Funding history
Date
Round
Amount
Jan 2023
Seed
Actimed Therapeutics, a UK specialty pharma, raised a GBP5M final seed tranche led by Mankind Pharma.
$6.2M
Investors
Mankind Pharma
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →